Symbol="RAPT"
AssetType="Common Stock"
Name="RAPT Therapeutics Inc"
Description="RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. The company is headquartered in South San Francisco, California."
CIK="1673772"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="662172000"
EBITDA="-104955000"
PERatio="None"
PEGRatio="None"
BookValue="5.81"
DividendPerShare="0"
DividendYield="0"
EPS="-2.7"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.299"
ReturnOnEquityTTM="-0.491"
RevenueTTM="0"
GrossProfitTTM="1527000"
DilutedEPSTTM="-2.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="40.58"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="266.16"
PriceToBookRatio="3.061"
EVToRevenue="171.65"
EVToEBITDA="-5.0"
Beta="0.344"
num_52WeekHigh="32.45"
num_52WeekLow="15.59"
num_50DayMovingAverage="21.43"
num_200DayMovingAverage="21.55"
SharesOutstanding="34345000"
DividendDate="None"
ExDividendDate="None"
symbol="RAPT"
open="19.41"
high="19.54"
low="18.30"
price="19.28"
volume="480149.00"
latest_trading_day="2023-08-17"
previous_close="19.41"
change="-0.12"
change_percent="-0.6442%"
aroon_positive_momentum_days="49"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="49"
Volume_recent_avg="328355"
Change_recent_avg="-0.05"
Delta_recent_avg="1.19"
Variance_recent_avg="0.59"
Change_ratio_recent_avg="-0.3"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="49"
Aroon_momentum_negative="51"
image_negative_thumbnail_id_1="1136"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_negative_thumbnail_id_2="1107"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0140.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="590"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_positive_thumbnail_id_1="978"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0140.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
